Clinical Study

Efficacy of Micromobile Foot Compression Device in Increasing Lower Limb Venous Blood Flow

Table 2

Clinical measurements with the MMC and GCS interventions, during seated immobility. Data are presented as mean (SD).

VariableTime in minutes
−30−103060
Mean (SD)

Peak systolic velocity (cm/s)
 MMC5.65 (1.08)5.27 (1.01)20.1 (6.77)20.1 (8.05)
 GCS5.61 (1.05)4.99 (1.02)5.66 (1.17)5.63 (1.13)

Mean flow velocity (cm/s)
 MMC2.30 (0.53)2.04 (0.47)5.78 (1.85)5.86 (2.08)
 GCS2.38 (0.48)2.06 (0.41)2.45 (0.48)2.38 (0.44)

Total volume flow (L/min)
 MMC0.10 (0.03)0.10 (0.04)0.29 (0.15)0.30 (0.17)
 GCS0.12 (0.03)0.11 (0.03)0.13 (0.04)0.12 (0.04)

Vein area (cm2)
 MMC0.74 (0.20)0.80 (0.24)0.83 (0.24)0.83 (0.27)
 GCS0.86 (0.24)0.87 (0.26)0.89 (0.26)0.82 (0.21)

Circumference (cm)
 MMC
  Ankle22.1 (1.6)22.2 (1.5)22.3 (1.5)22.4 (1.6)
  Calf38.0 (2.5)38.3 (2.5)38.5 (2.5)38.7 (2.5)
 GCS
  Ankle22.1 (1.6)22.3 (1.8)22.5 (1.5)22.6 (1.7)
  Calf38.0 (2.8)38.6 (2.5)37.6 (2.2)37.6 (2.2)